Financial and Non-Financial Support for Patient Organizations

This document outlines the financial and non-financial support provided to various patient organizations in North Macedonia. The support aims to assist these organizations in their mission to improve healthcare, raise awareness, and advocate for patients with specific conditions.

Name of Organization Country Type of Support Description of Support or Services Financial Value of Support and Invoiced Costs Non-Financial Support for the PO Remuneration for Paid Services
Association of Citizens for Rare Diseases "Life with Challenges" - Bitola Republic of North Macedonia Financial Support Partial support for organizing the planned annual activities of the Association of Citizens for Rare Diseases "Life with Challenges". 260,000.00
Association for Initiatives for Development in Healthcare, Improvement of Healthcare Services and Patient Advocacy EZRA Republic of North Macedonia Financial Support Financial support for the campaign for Breast Cancer Awareness Month. 90,000.00
Association for Better Health, Education and Social Care - SANO Republic of North Macedonia Financial Support Partial financial support for organizing an event. 178,750.00
Association for Rare Diseases - Rare to be Rare Republic of North Macedonia Financial Support Financial support for annual activities, support for the mission and goals of the association. 483,000.00
Association of Citizens MUSCULAR DYSTROPHY ASSOCIATION MACEDONIA, Negotino Republic of North Macedonia Financial Support Financial support for the mission, goals, and activities of the association. 220,000.00
Association of Citizens with Hemophilia - HEMOLOG Republic of North Macedonia Financial Support Financial support for the mission, goals, and activities of the association and honorarium for participation in the Roche event panel discussion. 587,100.00
Association of Citizens with Spinal Muscular Atrophy STOP SMA, Skopje Republic of North Macedonia Financial Support Financial support for the mission, goals, and activities of the association. 259,500.00
Association HEPAR CENTER, Bitola Republic of North Macedonia Financial Support Financial support for the mission, goals, and activities of the association. 450,000.00
National Association for Help and Support of People with MS Republic of North Macedonia Financial Support Financial support for the mission, goals, and activities of the association. 350,000.00
HEMA-ONKO, association dedicated to cancer patients and their caregivers Republic of North Macedonia Financial Support Financial support for the mission, goals, and activities of the association. 398,800.00

For more information on Roche's collaboration with patient organizations, please visit: Roche | Collaboration with patient organizations in a sustainable way.

PDF preview unavailable. Download the PDF instead.

pag-disclosure-final-2024 PDF-XChange Standard (10.5.0 build 393) [GDI] [Windows 11 Enterprise x64 (Build 22631)]

Related Documents

Preview Roche Pharma Day 2022: Strategy, Pipeline, and Growth Opportunities
Overview of Roche's Pharma Day 2022 event, detailing pharmaceutical strategy, pipeline advancements in oncology, hematology, neuroscience, ophthalmology, and infectious diseases, commercial opportunities, and future outlook.
Preview Tecentriq (Atezolizumab) Prescribing Information and Clinical Use
Comprehensive prescribing information for Tecentriq (atezolizumab), including therapeutic indications for various cancers like NSCLC, SCLC, TNBC, and HCC, dosage and administration guidelines, warnings, precautions, clinical trial data, and safety information.
Preview Roche Diagnostics Showcases Innovation at ADLM 2025 | Science-Driven Healthcare Solutions
Roche Diagnostics highlights its latest innovations in diagnostics, including AI solutions, cardiovascular and cervical cancer screening advancements, and new platform technologies at ADLM 2025 in Chicago. Learn about their commitment to improving patient outcomes and healthcare delivery.
Preview Roche Receives FDA Approval for VENTANA MET (SP44) RxDx Assay for Non-Small Cell Lung Cancer
Roche announces FDA approval of the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic to identify non-small cell lung cancer patients eligible for treatment with AbbVie's EMRELIS™.
Preview ACCU-CHEK ADVANTAGE CONTROL SOLUTION CA Safety Data Sheet
Safety Data Sheet for ACCU-CHEK ADVANTAGE CONTROL SOLUTION CA, providing comprehensive information on product identification, hazard assessment, composition, first aid measures, firefighting, accidental release, handling and storage, exposure controls, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, and regulatory information.
Preview Decentralized Care: A Path to Better Efficiency and Outcomes in Healthcare
This white paper explores the implementation of decentralized healthcare models based on the experiences of the UK, Singapore, the Netherlands, and Belgium. It details the key pillars of decentralized care: policy and regulation, technology and data, infrastructure and service delivery, and training. The document highlights the results, KPIs, and lessons learned from these countries in improving healthcare efficiency, patient access, and overall outcomes.
Preview Roche Diagnostics Indianapolis Campus Map and Directory
Detailed campus map and directory for Roche Diagnostics North America and Diabetes Care North America headquarters in Indianapolis, including a legend of facilities and driving directions to an off-campus site.
Preview cobas h 232 Quick Reference Guide | Roche Diagnostics
Concise guide for the Roche cobas h 232 point-of-care testing system, covering essential operational steps and sample results. Includes proBNP testing information.